Palivizumab prophylaxis in haemodynamically significant congenital heart disease

類似資料

• Low incidence of respiratory syncytial virus hospitalisations in haemodynamically significant congenital heart disease
  著者:: Duppenthaler, A, 等
  出版事項: (2004)
• Impact of Palivizumab on RSV Hospitalizations for Children with Hemodynamically Significant Congenital Heart Disease
  著者:: Chang, Ruey-Kang R., 等
  出版事項: (2009)
• Use of palivizumab in children with congenital heart disease
  出版事項: (2003)
• Palivizumab prophylaxis against respiratory syncytial virus infection in patients younger than 2 years of age with congenital heart disease
  著者:: Mohammed, Mohammed Hassan A., 等
  出版事項: (2021)
• Intraoperative Transesophageal Echocardiography for Congenital Heart Disease
  著者:: Feltes, Timothy F.
  出版事項: (1992)